Vol 15: Predictors of ICS-LABA prescribing in COPD patients: a study from general practice.Report as inadecuate



 Vol 15: Predictors of ICS-LABA prescribing in COPD patients: a study from general practice.


Vol 15: Predictors of ICS-LABA prescribing in COPD patients: a study from general practice. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 15: Predictors of ICS-LABA prescribing in COPD patients: a study from general practice.
This article is from BMC Family Practice, volume 15.AbstractBackground: A combination of inhaled corticosteroid and long-acting beta2 agonist ICS-LABA is used frequently to treat chronic obstructive pulmonary disease COPD patients. The aim of the study was to determine whether prescribing ICS-LABA to COPD patients in primary care in 2009-10 was within the GOLD guidelines and whether and to what degree patient characteristics were associated with prescription of these drugs by GPs. Methods: This was a cross-sectional study in seven Norwegian GP practices. Patients registered with a diagnosis of asthma or COPD in the previous five years were included. Results: Among the 376 patients included in the analysis, 149 patients had COPD, defined as a post-bronchodilator FEV1-FVC



Author: Drivenes, Elin; ?strem, Anders; Melbye, Hasse

Source: https://archive.org/







Related documents